Home > > > > Report Detail

Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic stroke (Clot retrievers, Aspiration, Microcatheters), AVM (Liquid Embolic Agents), End User (Hospitals), & Region - Global Forecast to 2028

Publisher Name :
Date: 04-May-2023
No. of pages: 263
Inquire Before Buying

“The rising cases of ischemic stroke and cerebral aneurysm worldwide is anticipated to fuel the demand for neurovascular devices”

The global neurovascular devices market is projected to reach USD 5.5 Billion by 2028 from USD 3.6 Billion in 2023, at a CAGR of 8.7% during the forecast period. The increase in the demand for neurovascular devices market is driven by the increasing population proportionat a risk of developing various neurovascular diseases such as Ischemic stroke, cerebral aneurysms owing to the growing prevalence of hypertension, diabetes, and obesity. However, high cost of neuro-interventional procedures and associated products and shortage of skilled neurologists across emerging countries are likely to hamper the growth of market.

“Ischemic stroke segment accounted for the highest CAGR  during the forecast period”

Based on disease pathology, the neurovascular devices market is segmented into cerebral aneurysm, ischemic strokes, carotid artery stenosis, arteriovenous malformations & fistulas, and other disease pathologies (includes cavernous malformations and moyamoya disease). The ischemic stroke segment to grow a at a higher CAGR owing to increasing incidence of ischemic stroke and increase in the mechanical thrombectomy procedures.

“The Hospitals & surgical centers segment accounted for the largest market share in the neurovascular devices market, by end user, during the forecast period”

Based on end user, the neurovascular devices market is segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories and academic institutes. The hospital & surgical centers captured the largest share of neurovascular devices market during the forecast period attributed to the increasing hospitalization of target patient population, rising volume of neurovascular surgeries, and upgradation in the infrastructure of hospitals in developing nations along with the availability of technological advance neurovascular treatment devices in these settings.

“The North America segment accounted for the highest market share in the neurovascular devices market, by region, during the forecast period”

Based on the region, the global neurovascular devices market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to witness a high market share during the forecast period. This can be attributed to the factors such as strong adoption of endovascular treatment procedures for the ischemic stroke, cerebral aneurysm, and arteriovenous malformation, availability of R& D investments for development of novel neurovascular devices, strong foothold of key players in region, and favorable reimbursement policy for neurovascular treatment procedures. 

Breakdown of supply-side primary interviews, by company type, designation, and region:


  • By Company Type: Tier 1 (30%), Tier 2 (45%), and Tier 3 (25%)

  • By Designation: C-level (20%), Director-level (20%), and Others (45%)

  • By Region: North America (40%), Asia- Pacific (30%), Europe (20%), Latin America (7%) and  Middle East & Africa(3%)


Prominent companies include Stryker  (US), Johnson & Johnson (US),Medtronic  (Ireland), Terumo Corporation (Japan), Penumbra, Inc. (US), MicroPort Scientific Corporation (China), Kaneka Corporation (Japan), BALT (France), Perflow Medical Ltd. (Israel), Phenox GmbH (Germany), Sensome (France), Evasc (Canada), Rapid Medical (Israel), Asahi Intecc Co., Ltd (Japan), Acandis GmbH (Germany), Medikit Co. Ltd. (Japan), Imperative Care (US), Lepu Medical Technology(Beijing)Co.,Ltd. (China), Cerus Endovascular Inc.  (USA), and Zylox-Tonbridge Medical Co., Ltd (China)

Research Coverage

This research report categorizes the neurovascular devices market by disease pathology (cerebral aneurysm, ischemic strokes, carotid artery stenos is, arteriovenous malformations & fistulas, and other disease pathologies), by end user (hospitals & surgical centers, ambulatory care centers, and research laboratories and academic institutes), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the neurovascular devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the neurovascular devices market. Competitive analysis of upcoming startups in the neurovascular devices market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall neurovascular devices market and the sub segments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:


  • Analysis of key drivers (rising incidence of neurovascular diseases, increasing neurovascular procedures, availability of medical reimbursement, and expansion of healthcare infrastructure across emerging nations), restraints (high neurovascular procedural & related devices cost and shortage of skilled neurosurgeon in emerging countries ), opportunities (increase in the preference of minimally invasive neurosurgical procedures and rising R& D activities in neurovascular therapies), and challenges (stringent regulatory approval process for neurovascular treatment devices) influencing the growth of the neurovascular devices market

  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the neurovascular devices market.

  • Market Development: Comprehensive information about lucrative markets – the report analyses the neurovascular devices market across varied regions.

  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the neurovascular devices market

  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Stryker  (US), Johnson & Johnson (US),Medtronic  (Ireland), Terumo Corporation (Japan), Penumbra, Inc. (US), MicroPort Scientific Corporation (China),among others in the neurovascular devices market strategies.

Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic stroke (Clot retrievers, Aspiration, Microcatheters), AVM (Liquid Embolic Agents), End User (Hospitals), & Region - Global Forecast to 2028

Table Of Contents

1 Introduction 34
1.1 Study Objectives 34
1.2 Market Definition 34
1.2.1 Inclusions And Exclusions 35
1.3 Study Scope 35
1.3.1 Markets Covered 35
1.3.2 Geographic Scope 36
1.3.3 Years Considered 36
1.4 Currency Considered 36
1.5 Market Stakeholders 37
1.6 Recession Impact 38

2 Research Methodology 39
2.1 Research Data 39
Figure 1 Research Design 39
2.1.1 Secondary Data 40
2.1.2 Primary Research 41
2.1.2.1 Key Data From Primary Sources 41
Figure 2 Breakdown Of Primary Interviews: Supply-Side And Demand-Side Participants 42
Figure 3 Neurovascular Devices Market: Breakdown Of Primaries 42
2.2 Market Size Estimation 42
Figure 4 Research Methodology: Hypothesis Building 43
2.2.1 Product-Based Market Estimation 44
2.2.2 Volume-Based Market Estimation 44
Figure 5 Market Size Estimation: Neurovascular Devices Market 45
2.2.3 Primary Research Validation 45
2.3 Data Triangulation 46
Figure 6 Data Triangulation Methodology 46
2.4 Research Assumptions And Limitations 47
2.4.1 Research Assumptions 47
2.4.2 Research Limitations 47
2.5 Recession Impact 48
Table 1 Global Inflation Rate Projection, 2021–2027 (% Growth) 48

3 Executive Summary 49
Figure 7 Neurovascular Devices Market, By Disease Pathology,2023 Vs. 2028 (Usd Million) 49
Figure 8 Hospitals And Surgical Centers Segment To Continue To Dominate Market During Forecast Period 50
Figure 9 Asia Pacific To Register Highest Cagr In Neurovascular Devices Market During Forecast Period 51

4 Premium Insights 52
4.1 Neurovascular Devices Market Overview 52
4.2 Neurovascular Devices Market, By Disease Pathology, 2023 Vs. 2028 (Usd Million) 53
Figure 10 Cerebral Aneurysms To Dominate Neurovascular Devices Market During Forecast Period 53
4.3 Neurovascular Devices Market, By Region And Disease Pathology (2022) 54
Figure 11 Cerebral Aneurysms Segment Accounted For Highest Marketshare In Us 54
4.4 Neurovascular Devices Market, By Country 55
Figure 12 China To Grow At Highest Cagr During Forecast Period 55

5 Market Overview 56
5.1 Introduction 56
5.2 Market Dynamics 56
Figure 13 Neurovascular Devices Market: Drivers, Restraints, Opportunities, And Challenges 56
5.2.1 Drivers 57
5.2.1.1 Rising Incidence Of Neurovascular Diseases 57
Figure 14 Proportion Of Geriatric To Total World Population, By Country,2020 Vs. 2030 (Million People) 58
5.2.1.2 Availability Of Medical Reimbursements For Neurovascular Procedures 58
Table 2 Us: Reimbursement For Interventional Neurology Procedures 59
5.2.1.3 Expansion Of Healthcare Infrastructure Across Emerging Economies 59
5.2.1.4 Rising Demand For Effective Neurovascular Therapies 60
5.2.2 Restraints 60
5.2.2.1 Shortage Of Skilled Neurosurgeons 60
5.2.2.2 High Procedural Cost Of Neurovascular Surgeries And Associated Products 61
5.2.3 Opportunities 61
5.2.3.1 Rising R&D Activities For Neurovascular Therapies 61
5.2.3.2 Growing Preference For Minimally Invasive Neurosurgical Procedures 62
5.2.4 Challenges 62
5.2.4.1 Stringent Regulatory Approval Process For Medical Devices 62
5.3 Supply Chain Analysis 64
Figure 15 Neurovascular Devices Market: Supply Chain Analysis 64
5.4 Value Chain Analysis 65
Figure 16 Value Chain Analysis: Maximum Value Added Through Regulation & Distribution Stages 65
5.5 Porter’s Five Forces Analysis 65
5.5.1 Overview 65
Table 3 Neurovascular Devices Market: Porter’s Five Forces Analysis 66
5.5.2 Threat Of New Entrants 66
5.5.3 Threat Of Substitutes 66
5.5.4 Bargaining Power Of Suppliers 66
5.5.5 Bargaining Power Of Buyers 67
5.5.6 Intensity Of Competitive Rivalry 67
5.6 Regulatory Landscape 67
5.6.1 North America 67
5.6.1.1 Us 67
Table 4 Us Fda: Medical Device Classification 68
Table 5 Us: Medical Device Regulatory Approval Process 68
5.6.1.2 Canada 69
5.6.2 Europe 69
5.6.3 Asia Pacific 69
5.6.3.1 China 69
5.6.3.2 Japan 70
5.6.3.3 India 70
5.6.3.4 South Korea 70
5.7 Reimbursement Scenario 71
Table 6 Reimbursement Codes For Various Procedures (2021) 71
5.8 Pricing Trend Analysis 74
5.8.1 Average Selling Price Of Neurovascular Devices, By Key Player, 2021 (Usd) 74
5.8.2 Average Selling Price Of Neurovascular Devices,By Region/Country, 2021 (Usd) 75
5.9 Patent Analysis 76
Figure 17 Top Patent Applicants For Orthopedic Devices,January 2012–March 2023 76
5.10 Trade Analysis 77
Table 7 Import Data For Hs Code 901890, By Country, 2017–2021 (Usd Million) 77
Table 8 Export Data For Hs Code 901890, By Country, 2016–2020 (Usd Million) 77
5.11 Ecosystem Map 78
5.12 Case Study Analysis 78
5.12.1 Stent-Assisted Coiling (Sac) Therapy For Intracranial Aneurysms 78
Table 9 Usage Of Intracranial Stents For Treatment Of Broad-Necked Intracranial Aneurysms 78
5.13 Key Conferences And Events In 2022–2023 79
Table 10 Neurovascular Devices Market: Detailed List Of Conferences And Events 79
Figure 18 Trends/Disruptions Impacting Customers’ Businesses 80
5.14 Stakeholders And Buying Criteria 81
5.14.1 Key Stakeholders 81
Figure 19 Influence Of Stakeholders On Buying Process For Key Applications 81
Table 11 Influence Of Stakeholders On Buying Process For Key Applicationsegments (%) 81
5.15 Key Buying Criteria 82
Figure 20 Key Buying Criteria For Neurovascular Devices 82
Table 12 Key Buying Criteria For Neurovascular Devices 82

6 Neurovascular Devices Market, By Disease Pathology 83
6.1 Introduction 84
Table 13 Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 84
Table 14 Neurovascular Devices Market, By Region, 2021–2028 (Usd Million) 84
Table 15 Neurovascular Devices Market, By End User, 2021–2028 (Usd Million) 85
6.2 Cerebral Aneurysms 85
Table 16 Neurovascular Devices Market For Cerebral Aneurysms, By Type,2021–2028 (Usd Million) 86
Table 17 Neurovascular Devices Market For Cerebral Aneurysms, By Region,2021–2028 (Usd Million) 86
Table 18 Neurovascular Devices Market For Cerebral Aneurysms, By End User,2021–2028 (Usd Million) 87
6.2.1 Embolic Coils 87
Table 19 Cerebral Aneurysms Market For Embolic Coils, By Region,2021–2028 (Usd Million) 88
Table 20 Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 88
6.2.1.1 Bare Detachable Coils 88
6.2.1.1.1 Significant Adoption Of Bare Detachable Coils By Neurosurgeons For Brain Aneurysm Treatment To Promote Growth 88
Table 21 Cerebral Aneurysms Market For Bare Detachable Coils, By Region,2021–2028 (Usd Million) 89
6.2.1.2 Coated Detachable Coils 89
6.2.1.2.1 High Cost Of Coated Detachable Coils To Limit Adoption 89
Table 22 Cerebral Aneurysms Market For Coated Detachable Coils, By Region,2021–2028 (Usd Million) 90
6.2.2 Flow Diversion Devices 90
6.2.2.1 Rising R&D Activities To Develop Novel Flow Diversion Devices To Promote Growth 90
Table 23 Cerebral Aneurysms Market For Flow Diversion Devices, By Region,2021–2028 (Usd Million) 91
6.2.3 Intracranial Stents 91
6.2.3.1 Increased Efficacy Of Stent-Assisted Coiling For Treatment Of Wide-Necked Intracranial Aneurysms To Boost Adoption 91
Table 24 Cerebral Aneurysms Market For Intracranial Stents, By Region,2021–2028 (Usd Million) 91
6.2.4 Microcatheters 92
6.2.4.1 Growing Number Of Neurovascular Procedures And Favorable Reimbursement Scenarios To Boost Demand 92
Table 25 Cerebral Aneurysms Market For Microcatheters, By Region,2021–2028 (Usd Million) 92
6.2.5 Guidewires 92
6.2.5.1 Growing Utilization Of Nitinol Guidewires For Cerebral Aneurysm Procedures To Boost Growth 92
Table 26 Cerebral Aneurysms Market For Guidewires, By Region,2021–2028 (Usd Million) 93
6.3 Ischemic Strokes 93
Table 27 Neurovascular Devices Market For Ischemic Stroke, By Region,2021–2028 (Usd Million) 94
Table 28 Neurovascular Devices Market For Ischemic Stroke, By Type2021–2028 (Usd Million) 94
Table 29 Neurovascular Devices Market For Ischemic Stroke, By End User,2021–2028 (Usd Million 95
6.3.1 Clot Retriever Devices 95
6.3.1.1 Growing Number Of Clinical Trials For Development Of Novel Clot Retriever Stents To Drive Market 95
Table 30 Ischemic Strokes Market For Clot Retriever Devices, By Region,2021–2028 (Usd Million) 96
6.3.2 Suction & Aspiration Devices 96
6.3.2.1 Rapid Commercialization Of Technologically Advanced Aspiration Devices For Ischemic Stroke Treatment To Support Market 96
Table 31 Ischemic Strokes Market For Suction & Aspiration Devices, By Region,2021–2028 (Usd Million) 97
6.3.3 Vascular Snares 97
6.3.3.1 Limited Procedural Benefits In Stroke Treatment To Limit Adoption Of Vascular Snares 97
Table 32 Ischemic Strokes Market For Vascular Snares, By Region,2021–2028 (Usd Million) 97
6.3.4 Microcatheters 98
6.3.4.1 High Demand For Minimally Invasive Treatment In Ischemic Strokes To Boost Adoption Of Microcatheters 98
Table 33 Ischemic Strokes Market For Microcatheters, By Region,2021–2028 (Usd Million) 98
6.3.5 Microguidewires 98
6.3.5.1 Increasing Innovations In Guidewires To Promote Growth 98
Table 34 Ischemic Strokes Market For Microguidewires, By Region,2021–2028 (Usd Million) 99
6.3.6 Balloon Catheters 99
6.3.6.1 Growing Recognition Of Benefits Associated With Balloon Catheters To Bolster Demand 99
Table 35 Ischemic Strokes Market For Balloon Catheters, By Region,2021–2028 (Usd Million) 100
6.4 Carotid Artery Stenosis 100
Table 36 Neurovascular Devices Market For Arteriovenous Carotid Artery Stenosis, By Region, 2021–2028 (Usd Million) 100
Table 37 Neurovascular Devices Market For Carotid Artery Stenosis, By Type,2021–2028 (Usd Million) 101
Table 38 Neurovascular Devices Market For Carotid Artery Stenosis, By End User, 2021–2028 (Usd Million) 101
6.4.1 Carotid Artery Stents 101
6.4.1.1 Growing Adoption Of Carotid Artery Stents For Carotid Intervention Procedures To Support Growth 101
Table 39 Carotid Artery Stenosis Market For Carotid Artery Stents, By Region,2021–2028 (Usd Million) 102
6.4.2 Embolic Protection Devices 103
6.4.2.1 Growing Utilization Of Distal Filters During Carotid Intervention Procedures To Promote Growth 103
Table 40 Carotid Artery Stenosis Market For Embolic Protection Devices, By Region, 2021–2028 (Usd Million) 103
6.4.3 Balloon Catheters 104
6.4.3.1 Growing Preference For Balloon Catheters To Improve Efficacy Of Carotid Intervention Procedures To Augment Growth 104
Table 41 Carotid Artery Stenosis Market For Balloon Catheters, By Region,2021–2028 (Usd Million) 104
6.5 Arteriovenous Malformation & Fistulas 104
Table 42 Neurovascular Devices Market For Arteriovenous Malformation & Fistulas, By Region, 2021–2028 (Usd Million) 105
Table 43 Neurovascular Devices Market For Arteriovenous Malformation & Fistulas, By Type, 2021–2028 (Usd Million) 105
Table 44 Neurovascular Devices Market For Arteriovenous Malformation & Fistulas, By End User, 2021–2028 (Usd Million) 105
6.5.1 Liquid Embolic Agents 106
6.5.1.1 Development Of Novel Liquid Embolic Agents Offering High Embolization Of Arteriovenous Fistulas To Support Growth 106
Table 45 Arteriovenous Malformation & Fistulas Market For Liquid Embolic Agents, By Region, 2021–2028 (Usd Million) 106
6.5.2 Occlusion Balloon Catheters 106
6.5.2.1 Growing Utilization Of Balloon Catheters For Avm Treatment To Support Growth 106
Table 46 Arteriovenous Malformation & Fistulas Market For Occlusion Balloon Catheters, By Region, 2021–2028 (Usd Million) 107
6.5.3 Microcatheters 107
6.5.3.1 Improved Compatibility Of Microcatheters With Embolic Agents To Boost Demand 107
Table 47 Arteriovenous Malformation & Fistulas Market For Microcatheters,By Region, 2021–2028 (Usd Million) 107
6.6 Other Disease Pathologies 108
Table 48 Neurovascular Devices Market For Other Disease Pathologies, By Region, 2021–2028 (Usd Million) 108
Table 49 Neurovascular Devices Market For Other Disease Pathologies, By End User, 2021–2028 (Usd Million) 108

7 Neurovascular Devices Market, By End User 109
7.1 Introduction 110
Table 50 Neurovascular Devices Market, By End User, 2021–2028 (Usd Million) 110
7.2 Hospitals And Surgical Centers 110
7.2.1 Increasing Volume Of Neurovascular Procedures Due To Availability Of Advanced Equipment To Drive Market 110
Table 51 Neurovascular Devices Market For Hospitals And Surgical Centers,By Region, 2021–2028 (Usd Million) 111
7.3 Ambulatory Care Centers 111
7.3.1 Operational And Economic Benefits Offered By Accs To Drive Market 111
Table 52 Neurovascular Devices Market For Ambulatory Care Centers, By Region, 2021–2028 (Usd Million) 112
7.4 Research Laboratories And Academic Institutes 112
7.4.1 Increasing Collaborations For Development Of Technologically Advanced Neurovascular Devices To Support Market Growth 112
Table 53 Neurovascular Devices Market For Research Laboratories And Academic Institutes, By Region, 2021–2028 (Usd Million) 113

8 Neurovascular Devices Market, By Region 114
8.1 Introduction 115
Table 54 Neurovascular Devices Market, By Region, 2021–2028 (Usd Million) 115
8.2 North America 115
8.2.1 North America: Recession Impact 116
Figure 21 Neurovascular Devices Market: North America Snapshot 117
Table 55 North America: Neurovascular Devices Market, By Country,2021–2028 (Usd Million) 117
Table 56 North America: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 118
Table 57 North America: Neurovascular Devices Market For Cerebral Aneurysms,By Type, 2021–2028 (Usd Million) 118
Table 58 North America: Cerebral Aneurysms Market For Embolic Coils, By Type, 2021–2028 (Usd Million) 119
Table 59 North America: Neurovascular Devices Market For Ischemic Strokes,By Type, 2021–2028 (Usd Million) 119
Table 60 North America: Neurovascular Devices Market For Carotid Artery Stenosis, By Type, 2021–2028 (Usd Million) 119
Table 61 North America: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 120
Table 62 North America: Neurovascular Devices Market, By End User,2021–2028 (Usd Million) 120
8.2.2 Us 120
8.2.2.1 Presence Of Established Neurovascular Device Manufacturers To Drive Market 120
Table 63 Us: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 121
Table 64 Us: Neurovascular Devices Market For Cerebral Aneurysms, By Type,2021–2028 (Usd Million) 121
Table 65 Us: Embolic Coils Market, By Type, 2021–2028 (Usd Million) 122
Table 66 Us: Neurovascular Devices Market For Ischemic Strokes, By Type,2021–2028 (Usd Million) 122
Table 67 Us: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 122
Table 68 Us: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 123
8.2.3 Canada 123
8.2.3.1 Large Target Pool For Ischemic Stroke Patients To Drive Market 123
Table 69 Canada: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 124
Table 70 Canada: Neurovascular Devices Market For Cerebral Aneurysms, By Type, 2021–2028 (Usd Million) 124
Table 71 Canada: Embolic Coils Market, By Type, 2021–2028 (Usd Million) 124
Table 72 Canada: Neurovascular Devices Market For Ischemic Strokes,By Type, 2021–2028 (Usd Million) 125
Table 73 Canada: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 125
Table 74 Canada: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 125
8.3 Europe 126
8.3.1 Europe: Recession Impact 126
Table 75 Europe: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 127
Table 76 Europe: Neurovascular Devices Market For Cerebral Aneurysms,By Type, 2021–2028 (Usd Million) 127
Table 77 Europe: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 128
Table 78 Europe: Neurovascular Devices Market For Ischemic Strokes, By Type,2021–2028 (Usd Million) 128
Table 79 Europe: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 128
Table 80 Europe: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 129
Table 81 Europe: Neurovascular Devices Market, By End User,2021–2028 (Usd Million) 129
8.3.2 Germany 129
8.3.2.1 Increasing Adoption Of Endovascular Coils And Stents To Drive Market 129
Table 82 Germany: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 130
Table 83 Germany: Neurovascular Devices Market For Cerebral Aneurysms,By Type, 2021–2028 (Usd Million) 130
Table 84 Germany: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 131
Table 85 Germany: Neurovascular Devices Market For Ischemic Strokes,By Type, 2021–2028 (Usd Million) 131
Table 86 Germany: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 131
Table 87 Germany: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 132
8.3.3 France 132
8.3.3.1 Growing Preference For Minimally Invasive Neurovascular Procedures To Drive Market 132
Table 88 France: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 133
Table 89 France: Neurovascular Devices Market For Cerebral Aneurysms,By Type, 2021–2028 (Usd Million) 133
Table 90 France: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 134
Table 91 France: Neurovascular Devices Market For Ischemic Stroke, By Type,2021–2028 (Usd Million) 134
Table 92 France: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 134
Table 93 France: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 135
8.3.4 Uk 135
8.3.4.1 Rising Government Initiatives To Increase Accessibility Of Neurovascular Procedures To Drive Market 135
Table 94 Uk: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 136
Table 95 Uk: Neurovascular Devices Market For Cerebral Aneurysms, By Type,2021–2028 (Usd Million) 136
Table 96 Uk: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 137
Table 97 Uk: Neurovascular Devices Market For Ischemic Strokes, By Type,2021–2028 (Usd Million) 137
Table 98 Uk: Neurovascular Devices Market For Carotid Artery Stenosis, By Type, 2021–2028 (Usd Million) 137
Table 99 Uk: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 138
8.3.5 Italy 138
8.3.5.1 Increasing Thrombectomy Treatment Rates To Drive Demand For Neurovascular Devices 138
Table 100 Italy: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 139
Table 101 Italy: Neurovascular Devices Market For Cerebral Aneurysms, By Type,2021–2028 (Usd Million) 139
Table 102 Italy: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 140
Table 103 Italy: Neurovascular Devices Market For Ischemic Strokes, By Type,2021–2028 (Usd Million) 140
Table 104 Italy: Neurovascular Devices Market For Carotid Artery Stenosis, By Type, 2021–2028 (Usd Million) 140
Table 105 Italy: Neurovascular Devices Market For Arteriovenous Malformationsand Fistulas, By Type, 2021–2028 (Usd Million) 141
8.3.6 Spain 141
8.3.6.1 Rising Number Of Clinical Trials For Interventional Neurovascular Procedures To Support Market Growth 141
Table 106 Spain: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 142
Table 107 Spain: Neurovascular Devices Market For Cerebral Aneurysms,By Type, 2021–2028 (Usd Million) 142
Table 108 Spain: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 143
Table 109 Spain: Neurovascular Devices Market For Ischemic Strokes, By Type,2021–2028 (Usd Million) 143
Table 110 Spain: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 143
Table 111 Spain: Neurovascular Devices Market For Arteriovenous Malformationsand Fistulas, By Type, 2021–2028 (Usd Million) 144
8.3.7 Rest Of Europe 144
Table 112 Rest Of Europe: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 145
Table 113 Rest Of Europe: Neurovascular Devices Market For Cerebral Aneurysms,By Type, 2021–2028 (Usd Million) 145
Table 114 Rest Of Europe: Cerebral Aneurysms Market For Embolic Coils, By Type, 2021–2028 (Usd Million) 146
Table 115 Rest Of Europe: Neurovascular Devices Market For Ischemic Strokes,By Type, 2021–2028 (Usd Million) 146
Table 116 Rest Of Europe: Neurovascular Devices Market For Carotid Artery Stenosis, By Type, 2021–2028 (Usd Million) 146
Table 117 Rest Of Europe: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 147
8.4 Asia Pacific 147
8.4.1 Asia Pacific: Recession Impact 148
Table 118 Asia Pacific: Neurovascular Devices Market, By Country,2021–2028 (Usd Million) 148
Table 119 Asia Pacific: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 149
Table 120 Asia Pacific: Neurovascular Devices Market For Cerebral Aneurysms,By Type, 2021–2028 (Usd Million) 149
Table 121 Asia Pacific: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 150
Table 122 Asia Pacific: Neurovascular Devices Market For Ischemic Strokes,By Type, 2021–2028 (Usd Million) 150
Table 123 Asia Pacific: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 150
Table 124 Asia Pacific: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 151
Table 125 Asia Pacific: Neurovascular Devices Market, By End User,2021–2028 (Usd Million) 151
Figure 22 Neurovascular Devices Market: Asia Pacific Snapshot 152
8.4.2 Japan 153
8.4.2.1 Favorable Reimbursement Policy For Adoption Of Neurovascular Procedures To Drive Market 153
Table 126 Japan: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 153
Table 127 Japan: Neurovascular Devices Market For Cerebral Aneurysms, By Type, 2021–2028 (Usd Million) 154
Table 128 Japan: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 154
Table 129 Japan: Neurovascular Devices Market For Ischemic Strokes, By Type,2021–2028 (Usd Million) 154
Table 130 Japan: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 155
Table 131 Japan: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 155
8.4.3 China 155
8.4.3.1 Robust Presence Of Neurovascular Device Manufacturers To Drive Market 155
Table 132 China: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 156
Table 133 China: Neurovascular Devices Market For Cerebral Aneurysms, By Type, 2021–2028 (Usd Million) 156
Table 134 China: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 157
Table 135 China: Neurovascular Devices Market For Ischemic Strokes, By Type,2021–2028 (Usd Million) 157
Table 136 China: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 157
Table 137 China: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 158
8.4.4 India 158
8.4.4.1 Supportive Government Initiatives To Drive Uptake For Neurovascular Devices 158
Table 138 India: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 159
Table 139 India: Neurovascular Devices Market For Cerebral Aneurysms, By Type,2021–2028 (Usd Million) 159
Table 140 India: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 160
Table 141 India: Neurovascular Devices Market For Ischemic Strokes, By Type,2021–2028 (Usd Million) 160
Table 142 India: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 160
Table 143 India: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 161
8.4.5 Australia 161
8.4.5.1 Rising Incidence Of Cerebrovascular Disease To Drive Market 161
Table 144 Australia: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 162
Table 145 Australia: Neurovascular Devices Market For Cerebral Aneurysms,By Type, 2021–2028 (Usd Million) 162
Table 146 Australia: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 163
Table 147 Australia: Neurovascular Devices Market For Ischemic Strokes,By Type, 2021–2028 (Usd Million) 163
Table 148 Australia: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 163
Table 149 Australia: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 164
8.4.6 South Korea 164
8.4.6.1 Health Insurance Coverage For Neurovascular Procedures To Support Market Growth 164
Table 150 South Korea: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 165
Table 151 South Korea: Neurovascular Devices Market For Cerebral Aneurysms,By Type, 2021–2028 (Usd Million) 165
Table 152 South Korea: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 166
Table 153 South Korea: Neurovascular Devices Market For Ischemic Strokes, By Type, 2021–2028 (Usd Million) 166
Table 154 South Korea: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 166
Table 155 South Korea: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 167
8.4.7 Rest Of Asia Pacific 167
Table 156 Rest Of Asia Pacific: Neurovascular Devices Market, By Disease Pathology, 2021–2028 (Usd Million) 167
Table 157 Rest Of Asia Pacific: Neurovascular Devices Market For Cerebral Aneurysms, By Type, 2021–2028 (Usd Million) 168
Table 158 Rest Of Asia Pacific: Cerebral Aneurysms Market For Embolic Coils, By Type, 2021–2028 (Usd Million) 168
Table 159 Rest Of Asia Pacific: Neurovascular Devices Market For Ischemic Strokes,By Type, 2021–2028 (Usd Million) 168
Table 160 Rest Of Asia Pacific: Neurovascular Devices Market For Carotid Artery Stenosis, By Type, 2021–2028 (Usd Million) 169
Table 161 Rest Of Asia Pacific: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 169
8.5 Latin America 169
8.5.1 Latin America: Recession Impact 169
Table 162 Latin America: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 170
Table 163 Latin America: Neurovascular Devices Market For Cerebral Aneurysms,By Type, 2021–2028 (Usd Million) 170
Table 164 Latin America: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 171
Table 165 Latin America: Neurovascular Devices Market For Ischemic Strokes,By Type, 2021–2028 (Usd Million) 171
Table 166 Latin America: Neurovascular Devices Market For Carotid Artery Stenosis, By Type, 2021–2028 (Usd Million) 171
Table 167 Latin America: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 172
Table 168 Latin America: Neurovascular Devices Market, By End User,2021–2028 (Usd Million) 172
8.5.2 Brazil 172
8.5.2.1 Increasing Awareness Initiatives On Stroke Symptoms To Drive Market 172
Table 169 Brazil: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 173
Table 170 Brazil: Neurovascular Devices Market For Cerebral Aneurysms,By Type, 2021–2028 (Usd Million) 173
Table 171 Brazil: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 174
Table 172 Brazil: Neurovascular Devices Market For Ischemic Strokes, By Type,2021–2028 (Usd Million) 174
Table 173 Brazil: Neurovascular Devices Market For Carotid Artery Stenosis, By Type, 2021–2028 (Usd Million) 174
Table 174 Brazil: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 175
8.5.3 Mexico 175
8.5.3.1 Increasing Incidence Of Neurovascular Diseases To Support Market Growth 175
Table 175 Mexico: Neurovascular Devices Market, By Disease Pathology,2021–2028 (Usd Million) 176
Table 176 Mexico: Neurovascular Devices Market For Cerebral Aneurysms, By Type, 2021–2028 (Usd Million) 176
Table 177 Mexico: Cerebral Aneurysms Market For Embolic Coils, By Type,2021–2028 (Usd Million) 177
Table 178 Mexico: Neurovascular Devices Market For Ischemic Strokes, By Type,2021–2028 (Usd Million) 177
Table 179 Mexico: Neurovascular Devices Market For Carotid Artery Stenosis,By Type, 2021–2028 (Usd Million) 177
Table 180 Mexico: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 178
8.5.4 Rest Of Latin America 178
Table 181 Rest Of Latin America: Neurovascular Devices Market, By Disease Pathology, 2021–2028 (Usd Million) 178
Table 182 Rest Of Latin America: Neurovascular Devices Market For Cerebral Aneurysms, By Type, 2021–2028 (Usd Million) 179
Table 183 Rest Of Latin America: Cerebral Aneurysms Market For Embolic Coils,By Type, 2021–2028 (Usd Million) 179
Table 184 Rest Of Latin America: Neurovascular Devices Market For Ischemic Strokes, By Type, 2021–2028 (Usd Million) 179
Table 185 Rest Of Latin America: Neurovascular Devices Market For Carotid Artery Stenosis, By Type, 2021–2028 (Usd Million) 180
Table 186 Rest Of Latin America: Neurovascular Devices Market For Arteriovenous Malformations And Fistulas, By Type, 2021–2028 (Usd Million) 180
8.6 Middle East & Africa 180
8.6.1 Shortage Of Neurosurgeons And Poor Healthcare Coverage To Restrain Market Growth 180
8.6.2 Middle East & Africa: Recession Impact 181
Table 187 Middle East & Africa: Neurovascular Devices Market For Cerebral Aneurysms, By Type, 2021–2028 (Usd Million) 181
Table 188 Middle East & Africa: Neurovascular Devices Market, By Disease Pathology, 2021–2028 (Usd Million) 182
Table 189 Middle East & Africa: Cerebral Aneurysms Market For Embolic Coils, By Type, 2021–2028 (Usd Million) 182
Table 190 Middle East & Africa: Neurovascular Devices Market For Ischemic Strokes,By Type, 2021–2028 (Usd Million) 183
Table 191 Middle East & Africa: Neurovascular Devices Market For Carotid Artery Stenosis, By Type, 2021–2028 (Usd Million) 183
Table 192 Middle East & Africa: Neurovascular Devices Market For Arteriovenous Malformations & Fistulas, By Type, 2021–2028 (Usd Million) 183
Table 193 Middle East & Africa: Neurovascular Devices Market, By End User, 2021–2028 (Usd Million) 184

9 Competitive Landscape 185
9.1 Introduction 185
9.1.1 Strategies Adopted By Key Players 185
Figure 23 Overview Of Strategies Adopted By Key Players (2019−2023) 186
9.2 Revenue Share Analysis 187
Figure 24 Revenue Share Analysis Of Top Players In Neurovascular Devices Market 187
9.3 Market Share Analysis 187
Figure 25 Neurovascular Devices Market Share, By Key Player (2022) 188
9.4 Competitive Leadership Mapping: Company Evaluation Quadrant (2022) 189
9.4.1 Stars 189
9.4.2 Emerging Leaders 189
9.4.3 Pervasive Players 189
9.4.4 Participants 189
Figure 26 Neurovascular Devices Market: Competitive Leadershipmapping For Key Players (2021) 190
9.5 Competitive Leadership Mapping: Startups/Sme Evaluation Quadrant (2022) 191
9.5.1 Progressive Companies 191
9.5.2 Responsive Companies 191
9.5.3 Dynamic Companies 191
9.5.4 Starting Blocks 191
Figure 27 Neurovascular Devices Market: Competitive Leadership Mapping For Smes/Startups (2022) 192
9.6 Neurovascular Devices Market: Footprint Analysis Of Leading Players 193
Table 194 Company Footprint Analysis 193
Table 195 Product Footprint 194
Table 196 Regional Footprint 195
9.6.1 Product Launches & Approvals 196
Table 197 Neurovascular Devices Market: Key Product Launches & Approvals (January 2019–March 2023) 196
9.6.2 Deals 196
Table 198 Neurovascular Devices Market: Key Deals (January 2019–March 2023) 196
9.6.3 Other Developments 197
Table 199 Neurovascular Devices Market: Other Developments(January 2019–March 2023) 197

10 Company Profiles 198
(Business Overview, Products Offered, Recent Developments, Mnm View Right To Win, Strategic Choices Made, Weaknesses And Competitive Threats) *
10.1 Key Players 198
10.1.1 Stryker 198
Table 200 Stryker: Business Overview 198
Figure 28 Stryker: Company Snapshot (2022) 199
10.1.2 Medtronic 203
Table 201 Medtronic: Business Overview 203
Figure 29 Medtronic: Company Snapshot (2022) 204
10.1.3 Johnson & Johnson 208
Table 202 Johnson & Johnson: Business Overview 208
Figure 30 Johnson & Johnson: Company Snapshot (2022) 209
10.1.4 Terumo Corporation 212
Table 203 Terumo Corporation: Business Overview 212
Figure 31 Terumo Corporation: Company Snapshot (2021) 213
10.1.5 Penumbra, Inc. 216
Table 204 Penumbra, Inc.: Business Overview 216
Figure 32 Penumbra, Inc.: Company Snapshot (2022) 217
10.1.6 Microport Scientific Corporation 219
Table 205 Microport Scientific Corporation: Business Overview 219
Figure 33 Microport Scientific Corporation: Company Snapshot (2022) 220
10.1.7 Balt 223
Table 206 Balt: Business Overview 223
10.1.8 Kaneka Corporation 226
Table 207 Kaneka Corporation: Business Overview 226
Figure 34 Kaneka Corporation: Company Snapshot (2022) 227
Table 208 Product Launches 228
10.1.9 Phenox Gmbh 229
Table 209 Phenox Gmbh: Business Overview 229
10.1.10 Asahi Intecc Co., Ltd 231
Table 210 Asahi Intecc Co., Ltd.: Business Overview 231
Figure 35 Asahi Intecc: Company Snapshot (2022) 231
10.1.11 Perflow Medical Ltd. 233
Table 211 Perflow Medical Ltd.: Business Overview 233
10.1.12 Rapid Medical 235
Table 212 Rapid Medical: Business Overview 235
10.1.13 Cerus Endovascular Inc. 237
Table 213 Cerus Endovascular Inc.: Business Overview 237
10.1.14 Acandis Gmbh 239
Table 214 Acandis Gmbh: Business Overview 239
Table 215 Acandis Gmbh: Products Offered 239
10.1.15 Evasc 241
Table 216 Evasc: Business Overview 241
10.1.16 Sensome 242
Table 217 Sensome: Business Overview 242
10.1.17 Lepu Medical Technology (Beijing) Co., Ltd. 243
Table 218 Lepu Medical Technology (Beijing) Co., Ltd.: Business Overview 243
Figure 36 Lepu Medical Technology (Beijing) Co., Ltd: Company Snapshot (2021) 244
10.1.18 Imperative Care 246
Table 219 Imperative Care: Business Overview 246
Table 220 Imperative Care: Product Launches And Approvals 247
10.1.19 Medikit Co., Ltd. 248
Table 221 Medikit Co., Ltd.: Business Overview 248
10.1.20 Zylox-Tonbridge Medicalco., Ltd. 249
Table 222 Zylox-Tonbridge Medical Co., Ltd.: Business Overview 249
Figure 37 Zylox-Tonbridge Medical Co., Ltd.: Company Snapshot (2021) 250
Table 223 Zylox-Tonbridge Medical Co., Ltd.: Product Launches And Approvals 251
10.2 Other Players 252
10.2.1 Silk Road Medical, Inc. 252
10.2.2 Artio Medical, Inc. 252
10.2.3 Ivascular 253
10.2.4 Oxfordendovascular 253
10.2.5 Neurovasc Technologies, Inc. 254
*Details On Business Overview, Products Offered, Recent Developments, Mnm View, Right To Win, Strategic Choices Made, Weaknesses And Competitive Threats Might Not Be Captured In Case Of Unlisted Companies.

11 Appendix 255
11.1 Discussion Guide 255
11.2 Knowledgestore: Marketsandmarkets’ Subscription Portal 259
11.3 Customization Options 261
11.4 Related Reports 262
11.5 Author Details 263

  • Global EMG Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 91
    An electromyograph is a machine used to detect and record The electrical potential generated by muscle cells when they are activated. These signals can be analyzed to detect medical abnormalities or to analyze The biomechanics of movement. The global EMG Equipment market was valued at US$ 345 million in 2023 and is anticipated to reach US$ 527.7 million by 2030, witnessing a CAGR of 6.0% during The forecast period 2024-2030. North American market for EMG Equipment is estimate......
  • Global Neuroendovascular Coil Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Endovascular coiling is a procedure performed to block blood flow into an aneurysm (a weakened area in The wall of an artery). Endovascular coiling is a more recent treatment for brain aneurysms; it has been used in patients since 1991. A Neuroendovascular Coil is used to treat an unruptured and ruptured brain aneurysm (a weakened area in The artery wall). The global Neuroendovascular Coil market was valued at US$ 967 million in 2023 and is anticipated to reach US$ 1276......
  • Global Deep Brain Stimulation Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Deep Brain Stimulation Devices market size was valued at US$ 1076.1 million in 2023. With growing demand in downstream market, the Deep Brain Stimulation Devices is forecast to a readjusted size of US$ 2219 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Deep Brain Stimulation Devices market. Deep Brain Stimulation Devices are expected to show stable......
  • Global Implantable Neurostimulation Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89
    According to our LPI (LP Information) latest study, the global Implantable Neurostimulation Devices market size was valued at US$ 6495.6 million in 2023. With growing demand in downstream market, the Implantable Neurostimulation Devices is forecast to a readjusted size of US$ 14020 million by 2030 with a CAGR of 11.6% during review period. The research report highlights the growth potential of the global Implantable Neurostimulation Devices market. Implantable Neurostimulation Devices ar......
  • Global Equipment for Neurosurgery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 85
    According to our LPI (LP Information) latest study, the global Equipment for Neurosurgery market size was valued at US$ million in 2023. With growing demand in downstream market, the Equipment for Neurosurgery is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Equipment for Neurosurgery market. Equipment for Neurosurgery are expected to show stable growth in the future market. How......
  • Global Neurostimulation Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Neurostimulation Devices market size was valued at US$ 6495.6 million in 2023. With growing demand in downstream market, the Neurostimulation Devices is forecast to a readjusted size of US$ 14110 million by 2030 with a CAGR of 11.7% during review period. The research report highlights the growth potential of the global Neurostimulation Devices market. Neurostimulation Devices are expected to show stable growth in the future m......
  • Global EEG Equipment Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 160
    According to our LPI (LP Information) latest study, the global EEG Equipment market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the EEG Equipment is forecast to a readjusted size of US$ 99.3 million by 2030 with a CAGR of 6.8% during review period. The research report highlights the growth potential of the global EEG Equipment market. EEG Equipment are expected to show stable growth in the future market. However, product differentiation, reducing ......
  • Global Neuro-Endoscopy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Neuro-Endoscopy market size was valued at US$ 188.5 million in 2023. With growing demand in downstream market, the Neuro-Endoscopy is forecast to a readjusted size of US$ 257.2 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Neuro-Endoscopy market. Neuro-Endoscopy are expected to show stable growth in the future market. However, product differentiatio......
  • Global Neurovascular Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Neurovascular Devices market size was valued at US$ 180.7 million in 2023. With growing demand in downstream market, the Neurovascular Devices is forecast to a readjusted size of US$ 266.4 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Neurovascular Devices market. Neurovascular Devices are expected to show stable growth in the future market. However......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs